Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
The Journal of Infectious Diseases|December 28, 2020
SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization TestingJennifer A Rathe, Emily A Hemann, Julie Eggenberger, et al.Mbio|May 27, 2025
Targeting the MEK1/2 pathway to combat <i>Staphylococcus aureus</i> infection and inflammation in cystic fibrosisEryn Zuiker, Gregory Serpa, Mithu De, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 20, 2023
A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine ImmunityEmily A Hemann, Megan L Knoll, Courtney R Wilkins, et al.JCI Insight|July 8, 2024
IFN-λ uniquely promotes CD8 T cell immunity against SARS-CoV-2 relative to type I IFNAbigail D Solstad, Parker J Denz, Adam D Kenney, et al.Biorxiv : the Preprint Server for Biology|September 4, 2023
Innate immune control of influenza virus interspecies adaptationParker J Denz, Samuel Speaks, Adam D Kenney, et al.Biorxiv : the Preprint Server for Biology|March 22, 2023
Gasdermin D promotes influenza virus-induced mortality through neutrophil amplification of inflammationSamuel Speaks, Ashley Zani, Abigail Solstad, et al.Nature Communications|October 31, 2024
Innate immune control of influenza virus interspecies adaptation via IFITM3Parker J Denz, Samuel Speaks, Adam D Kenney, et al.Plos Pathogens|August 16, 2019
STING is required for host defense against neuropathological West Nile virus infectionKathryn McGuckin Wuertz, Piper M Treuting, Emily A Hemann, et al.Biorxiv : the Preprint Server for Biology|January 4, 2022
Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in miceAshley Zani, Adam D Kenney, Jeffrey Kawahara, et al.Immunity|September 1, 2019
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III InterferonsAdriana Forero, Snehal Ozarkar, Hongchuan Li, et al.Pageof 5